PBH · Prestige Consumer Healthcare Inc.
$51.38
+0.06 (+0.12%)
At close · Aug 14
Market Cap
$2.43B
Shares
47.37M
Prestige Consumer Healthcare Inc. Earnings Call Transcripts
Every quarterly earnings call for Prestige Consumer Healthcare Inc. (PBH) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲4.7%
$289.27M
$51.02M
'23 Q2
22-11-03
▲0.4%
$275.52M
$51.95M
'23 Q3
23-02-02
▲7.1%
$285.87M
−$240.55M
'23 Q4
23-05-04
▲0.8%
$279.31M
$53.28M
'24 Q1
23-08-03
▼1%
$286.32M
$53.56M
'24 Q2
23-11-02
▲2.6%
$282.74M
$53.05M
'24 Q3
24-02-08
▼3.1%
$276.99M
$49.46M
'24 Q4
24-05-14
▼4.4%
$267.14M
$49.07M
'25 Q1
24-08-08
▼0.9%
$283.79M
$54.38M
'25 Q2
24-11-07
▲2.7%
$290.32M
$61.03M
'25 Q3
25-02-06
▲7%
$296.52M
$50.13M
'25 Q4
25-05-08
▼6.6%
$249.53M
$47.47M
'26 Q1
25-08-07
▼3.4%
$274.11M
$42.21M
'26 Q2
25-11-06
▼2.4%
$283.44M
$46.70M
'26 Q3
26-02-05
▼5%
$281.62M
$53.93M
'26 Q4
26-05-14
LATEST
▲6.5%
$265.71M
$29.18M
'27 Q1
26-08-06
Earnings call
FY27 · Q1
2026-08-06
Q1 2027 Prestige Consumer Healthcare Inc. Earnings Conference Call
Confident tone
Acquisitions (Breathe Right and Locorium Health)
ClearEyes recovery and Pillar 5 facility
Capital allocation and free cash flow
Revenue
$265.71M
▲ 6.5% YoY Diluted EPS
$0.61
▼ 35.8% YoY Gross margin
51.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Oppenheimer Annual Consumer Growth & E-Commerce Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q4
2026-05-14
Prestige Consumer Healthcare Inc. Q4 FY2026 Earnings Call
Positive tone
Fiscal 26 results
ClearEyes / iCare supply chain recovery
Pending M&A - Breathe Right and LeClorian
Revenue
$281.62M*
▼ 5% YoY Gross margin
51.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY26 · Q3
2026-02-05
Prestige Consumer Healthcare Inc. Q3 FY2026 Earnings Call
Positive tone
ClearEyes supply recovery
Capital allocation and shareholder returns
Diverse business model and channel mix
Revenue
$283.44M
▼ 2.4% YoY Diluted EPS
$0.97
▼ 20.5% YoY Gross margin
55.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2025-11-06
Prestige Consumer Healthcare Inc. Q2 FY2026 Earnings Call
Positive tone
Clear Eyes supply constraints and recovery
DenTek brand and dental guards
Gross margin and tariffs
Revenue
$274.11M
▼ 3.4% YoY Diluted EPS
$0.86
▼ 21.1% YoY Gross margin
55.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2025-08-07
Prestige Consumer Healthcare Inc. Q1 FY2026 Earnings Call
Revenue
$249.53M
▼ 6.6% YoY Diluted EPS
$0.95
▼ 3.1% YoY Gross margin
56.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-05-08
Prestige Consumer Healthcare Inc. Q4 FY2025 Earnings Call
Revenue
$296.52M*
▲ 7% YoY Gross margin
57.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-02-06
Prestige Consumer Healthcare Inc. Q3 FY2025 Earnings Call
Confident tone
Capital allocation and balance sheet
GI category growth (Dramamine, Fleet, Gaviscon)
Clear Eyes supply chain constraints recovery
Revenue
$290.32M
▲ 2.7% YoY Diluted EPS
$1.22
▲ 15.1% YoY Gross margin
55.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2024-11-07
Prestige Consumer Healthcare Inc. Q2 FY2025 Earnings Call
Revenue
$283.79M
▼ 0.9% YoY Diluted EPS
$1.09
▲ 1.9% YoY Gross margin
55.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2024-08-08
Prestige Consumer Healthcare Inc. Q1 FY2025 Earnings Call
Revenue
$267.14M
▼ 4.4% YoY Diluted EPS
$0.98
▼ 7.5% YoY Gross margin
54.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-05-14
Prestige Consumer Healthcare Inc. Q4 FY2024 Earnings Call
Revenue
$276.99M*
▼ 3.1% YoY Gross margin
54.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-02-08
Prestige Consumer Healthcare Inc. Q3 FY2024 Earnings Call
Revenue
$282.74M
▲ 2.6% YoY Diluted EPS
$1.06
▲ 1.9% YoY Gross margin
55.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2023-11-02
Prestige Consumer Healthcare Inc. Q2 FY2024 Earnings Call
Revenue
$286.32M
▼ 1% YoY Diluted EPS
$1.07
▲ 4.9% YoY Gross margin
55.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2023-08-03
Prestige Consumer Healthcare Inc. Q1 FY2024 Earnings Call
Revenue
$279.31M
▲ 0.8% YoY Diluted EPS
$1.06
▼ 2.8% YoY Gross margin
55.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-05-04
Prestige Consumer Healthcare Inc. Q4 FY2023 Earnings Call
Revenue
$285.87M*
▲ 7.1% YoY Gross margin
53.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-02-02
Prestige Consumer Healthcare Inc. Q3 FY2023 Earnings Call
Revenue
$275.52M
▲ 0.4% YoY Diluted EPS
$1.04
▲ 5.1% YoY Gross margin
54.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2022-11-03
Prestige Consumer Healthcare Inc. Q2 FY2023 Earnings Call
Revenue
$289.27M
▲ 4.7% YoY Diluted EPS
$1.02
▲ 14.6% YoY Gross margin
55.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2022-08-04
Prestige Consumer Healthcare Inc. Q1 FY2023 Earnings Call
Revenue
$277.06M
▲ 2.9% YoY Diluted EPS
$1.09
▼ 4.4% YoY Gross margin
57.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-05-05
Prestige Consumer Healthcare Inc. Q4 FY2022 Earnings Call
Revenue
$266.94M*
▲ 12.3% YoY Gross margin
55.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-02-03
Prestige Consumer Healthcare Inc. Q3 FY2022 Earnings Call
Revenue
$274.47M
▲ 14.9% YoY Diluted EPS
$0.99
▲ 22.2% YoY Gross margin
56.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2021-11-04
Prestige Consumer Healthcare Inc. Q2 FY2022 Earnings Call
Revenue
$276.23M
▲ 16.3% YoY Diluted EPS
$0.89
▲ 1.1% YoY Gross margin
57.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-08-05
Prestige Consumer Healthcare Inc. Q1 FY2022 Earnings Call
Revenue
$269.18M
▲ 17.3% YoY Diluted EPS
$1.14
▲ 32.6% YoY Gross margin
59.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-05-06
Prestige Consumer Healthcare Inc. Q4 FY2021 Earnings Call
Revenue
$237.76M*
▼ 5.4% YoY Gross margin
57.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-02-04
Prestige Consumer Healthcare Inc. Q3 FY2021 Earnings Call
Revenue
$238.79M
▼ 1.1% YoY Diluted EPS
$0.81
▲ 8% YoY Gross margin
58.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2020-11-05
Prestige Consumer Healthcare Inc. Q2 FY2021 Earnings Call
Revenue
$237.42M
▼ 0.3% YoY Diluted EPS
$0.88
▲ 35.4% YoY Gross margin
58.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2020-08-06
Prestige Consumer Healthcare Inc. Q1 FY2021 Earnings Call
Revenue
$229.39M
▼ 1.2% YoY Diluted EPS
$0.86
▲ 32.3% YoY Gross margin
58.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-05-07
Prestige Consumer Healthcare Inc. Q4 FY2020 Earnings Call
Revenue
$251.24M
▲ 4.2% YoY Diluted EPS
$0.73
Gross margin
57.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-02-06
Prestige Consumer Healthcare Inc. Q3 FY2020 Earnings Call
Revenue
$241.55M
▲ 0.1% YoY Diluted EPS
$0.75
▲ 2.7% YoY Gross margin
56.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2019-06-30
Prestige Consumer Healthcare Inc. Q1 FY2020 Earnings Call
Revenue
$232.15M
▼ 8.6% YoY Diluted EPS
$0.65
▲ 0% YoY Gross margin
57.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–29 of 29 earnings calls
Key facts
CIK
1295947
CUSIP
74112D101
13F (30d)
293 filings
293 filers
Visit website
Investor relations